Essa, N.M.; Salem, H.F.; Elgendy, M.O.; Gabr, A.; Omran, M.M.; Hassan, N.A.; Tashkandi, H.M.; Harakeh, S.; Boshra, M.S.
Efficacy of Metformin as Adjuvant Therapy in Metastatic Breast Cancer Treatment. J. Clin. Med. 2022, 11, 5505.
https://doi.org/10.3390/jcm11195505
AMA Style
Essa NM, Salem HF, Elgendy MO, Gabr A, Omran MM, Hassan NA, Tashkandi HM, Harakeh S, Boshra MS.
Efficacy of Metformin as Adjuvant Therapy in Metastatic Breast Cancer Treatment. Journal of Clinical Medicine. 2022; 11(19):5505.
https://doi.org/10.3390/jcm11195505
Chicago/Turabian Style
Essa, Nourhan M., Heba F. Salem, Marwa O. Elgendy, A. Gabr, Mervat M. Omran, Nivin A. Hassan, Hanaa M. Tashkandi, Steve Harakeh, and Marian S. Boshra.
2022. "Efficacy of Metformin as Adjuvant Therapy in Metastatic Breast Cancer Treatment" Journal of Clinical Medicine 11, no. 19: 5505.
https://doi.org/10.3390/jcm11195505
APA Style
Essa, N. M., Salem, H. F., Elgendy, M. O., Gabr, A., Omran, M. M., Hassan, N. A., Tashkandi, H. M., Harakeh, S., & Boshra, M. S.
(2022). Efficacy of Metformin as Adjuvant Therapy in Metastatic Breast Cancer Treatment. Journal of Clinical Medicine, 11(19), 5505.
https://doi.org/10.3390/jcm11195505